GlassScriptPrepare for your visit
Sandee Guerrero
Family · Laredo, TX · NPI 1578339305
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,514.24
in general payments reported to CMS, 2019-2025 · $1,122 in 2025
The $1,122 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Janssen Biotech, INC. $404.20
- Galderma Laboratories, L.P. $271.70
- Genzyme Corporation $196.00
- Regeneron Healthcare Solutions, INC. $178.14
- Amgen INC. $162.42
- Organon LLC $95.68
Drugs and devices associated with these payments
Dupixent Tremfya Nemluvio Otezla Kerecis Omega3 Marigen Ilumya Kerecis Omega3 Surgiclose Opzelura Skyrizi Nexplanon Olumiant Zoryve
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sandee Guerrero listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11535472/sandee-guerrero